FDA Adverse Event Injury Summary report: N

UNK

MDR report key: 1015573 · Received March 19, 2008

Report

Report Number
2182207-2008-01383
Event Type
Injury
Date Received
March 19, 2008
Report Date
February 28, 2008
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
EZW
PMA / PMN Number
P970004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

JOURNAL REFERENCE: CHUNG ET AL. "EFFICACY AND SAFETY OF SACRAL NEUROMODULATION (INTERSTIM) FOR THE TREATMENT OF REFRACTORY OVERACTIVE BLADDER SYMPTOMS AND CHRONIC PELVIC PAIN." KOREAN J UROL 2007; 48(7):701-705.

Description of Event or Problem · 1

JOURNAL REFERENCE: CHUNG ET AL. "EFFICACY AND SAFETY OF SACRAL NEUROMODULATION (INTERSTIM) FOR THE TREATMENT OF REFRACTORY OVERACTIVE BLADDER SYMPTOMS AND CHRONIC PELVIC PAIN." KOREAN J UROL 2007; 48(7):701-705. THE AUTHORS EVALUATED THE EFFICACY AND SAFETY TO SACRAL NEUROMODULATION FOR TREATING PATIENTS SUFFERING WITH AN OVERACTIVE BLADDER (OAB) OR CHRONIC PELVIC PAIN (CPP) THAT WAS REFRACTORY TO CONSERVATIVE THERAPIES. A TOTAL OF 30 PTS UNDERWENT TESTING WITH SACRAL NERVE MODULATION VIA EITHER A TRADITIONAL PERCUTANEOUS APPROACH OR A STAGED PROCEDURE TO PREDICT THE EFFICACY OF THIS TREATMENT FOR REFRACTORY OAB AND/OR CPP. SEVENTEEN PATIENTS UNDERWENT A PROCEDURE TO IMPLANT A PERMANENT SACRAL NERVE STIMULATION. AVERAGE FOLLOW-UP WAS 21.6 MONTHS. REPORTABLE EVENT: THE COMPLICATIONS REPORTED RELATED TO THE SURGICAL OPERATIONS INCLUDED TWO CASES OF LEG NUMBNESS, THE PTS SIMULTANEOUSLY UNDERWENT THE CONSERVATIVE TREATMENT SUCH AS THE ADMINISTRATION OF ANALGESICS TOGETHER WITH SACRAL NEUROMODULATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNK EZW MEDTRONIC NEUROMODULATION LEAD UNK

Patients

Seq Age Sex Outcome Treatment
1 UNK Other PROGRAMMER MODEL: UNK| IMPLANTABLE PULSE GENERATOR: MODEL 3023